Immune Complex Diseases: Clinical Trials

9 trials for Immune Complex Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 2 unknown, 1 active not recruiting. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Recruiting 3, Completed 2, Unknown 2, Active not recruiting 1, Terminated 1

Follow Immune Complex Diseases: new trials by email Literature Review of Immune Complex Diseases trials Research Report on Immune Complex Diseases

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
Bezuclastinib Tablets (Formulation A), Bezuclastinib Tablets (Formulation B), Placebo Tablets - SSM, Mastocytosis, Indolent
Phase 2Active not recruitingCogent Biosciences, Inc.2372022-06-272026-10-22
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
bezuclastinib - Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN)
Phase 2RecruitingCogent Biosciences, Inc.1402021-11-092026-09-15
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Sparsentan - Focal Segmental Glomerulosclerosis, Minimal Change Disease
Phase 2RecruitingTravere Therapeutics, Inc.672021-08-122026-05-12
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis
Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis
Phase 2TerminatedCambridge University Hospitals NHS Foundation Trust222021-07-142025-06-17
Flu Vaccine Response in Patients on Biologic Therapies
Influenza vaccine - Rheumatologic Disorder, Inflammatory Bowel Diseases
Phase 2CompletedStony Brook University302017-11-032026-08-06
A Randomized Multicenter Study for Isolated Skin Vasculitis
Colchicine, Dapsone, Azathioprine - Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa
Phase 2RecruitingUniversity of Pennsylvania902017-01-012026-08-20
The Research of Standard Diagnosis and Treatment for Severe HSP in Children
Dexamethasone, Gamma globulin, Hemoperfusion - Henoch-Schoenlein Purpura
Phase 2UnknownNanjing Children's Hospital302015-08-012020-02-26
Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura
Placebo, "ziying" granules - Purpura, Schoenlein-Henoch
Phase 2UnknownLiaoning University of Traditional Chinese Medicine2562009-11-012010-09-08
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
Methylprednisolone, Prednisolone - Vasculitis, Hypersensitivity, Connective Tissue Diseases
Phase 2CompletedNorthwestern University61997-09-012011-07-22

Narrower conditions

IgA Vasculitis (5)  ·  Hematologic Diseases (2)  ·  Hypersensitivity (2)  ·  Immune System Diseases (2)  ·  Mastocytosis (2)  ·  Mastocytosis, Systemic (2)  ·  Vasculitis (2)  ·  Cardiovascular Diseases (1)  ·  Cogan Syndrome (1)  ·  Collagen Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Cryoglobulinemia, Familial Mixed (1)  ·  Dermatomyositis (1)  ·  Giant Cell Arteritis (1)

Broader conditions

Skin and Connective Tissue Diseases (8)  ·  Hemic and Lymphatic Diseases (7)  ·  Hypersensitivity (7)  ·  Immune System Diseases (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Skin Diseases (6)  ·  Skin Diseases, Vascular (6)  ·  Vascular Diseases (6)  ·  Blood Coagulation Disorders (5)  ·  Cardiovascular Diseases (5)  ·  Hematologic Diseases (5)  ·  Hemorrhage (5)  ·  Hemorrhagic Disorders (5)

Interventions

Azathioprine (1)  ·  Colchicine (1)  ·  Dapsone (1)  ·  Dexamethasone (1)  ·  Hemoperfusion (1)  ·  Infliximab (1)  ·  Influenza Vaccines (1)  ·  Methylprednisolone (1)  ·  Prednisolone (1)  ·  Rituximab (1)  ·  gamma-Globulins (1)  ·  sparsentan (1)  ·  tocilizumab (1)

Sponsors

Cogent Biosciences, Inc. (2)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Liaoning University of Traditional Chinese Medicine (1)  ·  Nanjing Children's Hospital (1)  ·  Northwestern University (1)  ·  Stony Brook University (1)  ·  Travere Therapeutics, Inc. (1)  ·  University of Pennsylvania (1)

Countries

United States (6)  ·  United Kingdom (4)  ·  Canada (3)  ·  Germany (3)  ·  Italy (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Spain (3)  ·  Australia (2)  ·  Belgium (2)  ·  China (2)  ·  France (2)  ·  Norway (2)  ·  Switzerland (2)  ·  Austria (1)

Top investigators

Aihua Zhang, M.D. (1)  ·  Christian Pagnoux, MD, MPH, MSc (1)  ·  Christy A Beneri, DO (1)  ·  David Jayne (1)  ·  Lauren M. Pachman, MD (1)  ·  Rachael Easton, MD, Ph.D. (1)  ·  Rachael Easton, MD, PhD (1)  ·  Radko Komers, MD, PhD (1)  ·  Robert Micheletti, MD (1)

Results publications

PMID 36853224, PMID 32345372, PMID 38724717, PMID 40938675, PMID 42384439

NIH funding

U54AR057319 (1)